CVR: 41191007
DKK -41,283
Gross profit
Net result: DKK -54,301
No owners listed
CVR · view ownership and management
Director role ended: John Bondo Hansen
CVR · 06/10/2023
View the full event history
Preo Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2020 and dissolved in 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity in the 2022 report amounted to DKK 54,270.
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. Preo Pharma ApS is registered in the Danish CVR register with the status Dissolved and ceased on 6 October 2023.
Preo Pharma ApS was founded on 24 February 2020.
Preo Pharma ApS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
In 2022, Preo Pharma ApS reported a gross profit of DKK -41,283.
Preo Pharma ApS was located at Langelinie Allé 7 4. 3, 2100 København Ø.
The CVR number of Preo Pharma ApS is 41191007.
As of October 6, 2023, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of Preo Pharma ApS.
As of October 6, 2023, John Bondo Hansen has stepped down as liquidator of Preo Pharma ApS.
On October 6, 2023, Preo Pharma ApS exited liquidation.
Preo Pharma ApS was dissolved on October 6, 2023.
As of June 2, 2023, John Bondo Hansen is registered as liquidator of Preo Pharma ApS.
As of June 2, 2023, John Bondo Hansen has stepped down as director of Preo Pharma ApS.
On June 2, 2023, Preo Pharma ApS entered liquidation.
Preo Pharma ApS has published its annual report for 2022. Gross profit came to DKK -41,283, and the net result was DKK -54,301.
Preo Pharma ApS has published its annual report for 2021. Gross profit came to DKK 294,880, and the net result was DKK 188,655.
Preo Pharma ApS has published its interim report for the period February 24, 2020 – December 31, 2020.
As of February 24, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Preo Pharma ApS.
As of February 24, 2020, John Bondo Hansen is registered as director of Preo Pharma ApS.
Preo Pharma ApS was founded on February 24, 2020.
Companies in the same industry and area
CVR 40243224
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
